You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Chapter title |
Chimeric Antigen Receptor (CAR) T Cell Therapy for Cancer. Challenges and Opportunities: An Overview
|
---|---|
Chapter number | 14 |
Book title |
Cancer Cell Signaling
|
Published by |
Humana, New York, NY, August 2020
|
DOI | 10.1007/978-1-0716-0759-6_14 |
Pubmed ID | |
Book ISBNs |
978-1-07-160758-9, 978-1-07-160759-6
|
Authors |
Arimelek Cortés-Hernández, Evelyn Katy Alvarez-Salazar, Gloria Soldevila, Cortés-Hernández, Arimelek, Alvarez-Salazar, Evelyn Katy, Soldevila, Gloria |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Saudi Arabia | 2 | 33% |
United States | 1 | 17% |
India | 1 | 17% |
Unknown | 2 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 67% |
Science communicators (journalists, bloggers, editors) | 1 | 17% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 24% |
Student > Master | 2 | 12% |
Lecturer | 1 | 6% |
Student > Doctoral Student | 1 | 6% |
Other | 1 | 6% |
Other | 4 | 24% |
Unknown | 4 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 24% |
Medicine and Dentistry | 4 | 24% |
Agricultural and Biological Sciences | 1 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Immunology and Microbiology | 1 | 6% |
Other | 1 | 6% |
Unknown | 5 | 29% |